Ignite Creation Date:
2025-12-24 @ 2:55 PM
Ignite Modification Date:
2026-01-03 @ 5:48 AM
Study NCT ID:
NCT03246659
Status:
COMPLETED
Last Update Posted:
2020-03-20
First Post:
2017-07-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Radiolabelled CCK-2/Gastrin Receptor Analogue for Personalized Theranostic Strategy in Advanced MTC
Sponsor:
Paola Anna Erba
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Medullary Thyroid Carcinoma | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | medullary thyroid carcinoma | View |
| None | MTC | View |
| None | new gastrin analog | View |
| None | 111In-CP04 | View |
| None | CP04 indium | View |
| None | personalised diagnostics | View |
| None | personalised therapy | View |
| None | theranostics | View |
| None | advanced MTC | View |
| None | CCK-2/gastrin receptor | View |